Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to find out more about the drug treprostinil via inhaler and the mechanisms of why patients with pulmonary arterial hypertension related to Interstitial Lung dise...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
Collaborators
NCT07481981 · Pulmonary Arterial Hypertension
NCT07615504 · Interstitial Lung Disease (ILD)
NCT07365332 · Pulmonary Arterial Hypertension
NCT07218029 · Pulmonary Arterial Hypertension
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
Mayo Clinic in Rochester
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions